首页> Diabetes: A Journal of the American Diabetes Association> Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats.

Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats.

导出原文传递

翻译打印收藏纠错

第一作者： Kochakian M

作者： Kochakian M ^[1] ; Manjula BN ^[2] ; Egan JJ

作者单位： Department of Biochemistry, Alteon, Inc., Ramsey, New Jersey, USA. ^[1] sk2.am.lodz.pl ^[2]

关键词 Collagen Diabetes Mellitus Experimental Guanidines Hydroxybenzoic Acids 胶原糖尿病实验性胍类羟基苯甲酸类尾腱

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes

1996年45卷12期

1694-1700页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Diabetes

1996年45卷12期

1694-1700页

检索历史清除

Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats.

Diabetes

相似文献

同项目论文

Diabetes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats.

Diabetes

相似文献

同项目论文

Diabetes

相关期刊

检索历史清除